Position in JNJ
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$859,417,971
+$35,263,824 QoQ
Shares Held
3,383,935
+0.4% QoQ
Ownership
0.140%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#71
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $4,805,415,142 across 12 Drug Manufacturers - General names. JNJ ranks #2 (17.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,255,719 | $1,506,147,163 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
3,383,935 | $859,417,971 | |
| 3 | ABBV |
AbbVie Inc.
|
2,684,208 | $675,454,100 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,751,479 | $610,565,050 | |
| 5 | NVS |
Novartis AG
|
1,565,796 | $245,391,548 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,793,779 | $226,626,038 | |
| 7 | AMGN |
Amgen Inc
|
614,341 | $222,465,162 | |
| 8 | PFE |
Pfizer Inc
|
6,346,636 | $152,826,994 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $859,417,971 | 3,383,935 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $824,154,147 | 3,371,601 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $705,736,129 | 3,410,177 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $627,054,653 | 3,381,807 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $547,290,265 | 3,582,915 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $562,754,656 | 3,393,359 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $496,333,236 | 3,431,982 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $562,722,882 | 3,472,312 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $459,357,347 | 3,142,839 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $501,952,688 | 3,173,100 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $492,095,574 | 3,139,566 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $483,204,251 | 3,102,435 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $553,761,394 | 3,345,586 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $525,817,040 | 3,392,368 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $591,810,003 | 3,350,184 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $573,761,159 | 3,512,250 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $599,000,216 | 3,374,459 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $609,214,300 | 3,437,422 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $597,913,769 | 3,495,141 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $602,274,681 | 3,729,255 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $632,257,786 | 3,837,913 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $621,465,364 | 3,781,353 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $634,834,721 | 4,033,770 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $620,668,957 | 4,168,921 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $625,107,240 | 4,445,049 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $562,863,591 | 4,292,409 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||